NCT04853173 Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults
| NCT ID | NCT04853173 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Tonsillar Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2021-06-09 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2021-06-09 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
No SFORL recommendation for adult ambulatory tonsillectomy. This study would allow the establishment of an ambulatory management during an adult tonsillectomy. This would allow a return home from J0 for the patient and therefore would improve the comfort of the patients and reduce the cost associated with a conventional hospitalization over several days.
Eligibility Criteria
Inclusion Criteria: * programmed Tonsillectomy surgery Exclusion Criteria: * Congenital or acquired hemostasis disorder * Indication of uvulo-bike-pharyngo-plasty * Contraindication to the use of one of the protocol molecules including pregnancy * Allergy to analgesic treatments used in the study * Ongoing analgesic treatment that cannot be interrupted
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04853173 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tonsillar Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04853173 currently recruiting?
Yes, NCT04853173 is actively recruiting participants. Contact the research team at ltavernier@chu-besancon.fr for enrollment information.
Where is the NCT04853173 trial being conducted?
This trial is being conducted at Besançon, France.
Who is sponsoring the NCT04853173 clinical trial?
NCT04853173 is sponsored by Centre Hospitalier Universitaire de Besancon. The trial plans to enroll 30 participants.